Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-02-20 @ 8:08 PM
Study NCT ID:
NCT00115635
Status:
COMPLETED
Last Update Posted:
2007-10-02
First Post:
2005-06-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer
Sponsor:
Herlev Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UR0416
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None